Journal Article (Editorial)

DZNE-2024-01190

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Neuroimaging biomarkers in the biological definition of Parkinson's disease and dementia with Lewy bodies - EANM position on current state, unmet needs and future perspectives.

Brendel, M. (First author)DZNE* ; Guedj, E. ; Yakushev, I. ; Morbelli, S. ; Höglinger, G. U.DZNE* ; Tolboom, N. ; Verger, A. ; Albert, N. L. ; Cecchin, D. ; Fernandez, P. A. ; Fraioli, F. ; Traub-Weidinger, T. ; Van Weehaeghe, D. ; Barthel, H.

2024
Springer-Verl. Heidelberg [u.a.]

This record in other databases:    

Please use a persistent id in citations: doi:10.1007/s00259-024-06803-w

Keyword(s): Humans (MeSH) ; Lewy Body Disease: diagnostic imaging (MeSH) ; Parkinson Disease: diagnostic imaging (MeSH) ; Biomarkers: metabolism (MeSH) ; Neuroimaging: methods (MeSH) ; Europe (MeSH) ; Biomarkers

---

Contributing Institute(s):

1. Molecular Neurodegeneration (AG Haass)
2. Clinical Research (Munich) (Clinical Research (Munich))
3. Translational Neurodegeneration (AG Höglinger)

Research Program(s):

1. 352 - Disease Mechanisms (POF4-352) (POF4-352)
2. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2024

---

Database coverage:
; ; ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---